Abstract

The mechanism by which baicalin modulated the expression of inducible nitric oxide synthase (iNOS) and nitric oxide (NO) in the mucosa of distal ileum was investigated in a rat model of acute endo-toxemia induced by intraperitoneal injection of bacterial lipopolysaccharide (LPS). The experiment demonstrated that LPS upregulated iNOS mRNA and protein expression as well as NO produc-tion (measured as the stable degradation production, nitrites). LPS not only increased toll-like receptor 4 (TLR4) and peroxisome proliferator-activated receptor gamma (PPARγ) content, but also activated p38 and activating transcription factor 2 (ATF2) and inactivated PPARγ via phosphorylation. Inhibition of p38 signalling pathway by chemical inhibitor SB202190 and small interfering RNA (siRNA) ameliorated LPS-induced iNOS generation, while suppression of PPARγ pathway by SR-202 boosted LPS-elicited iNOS expression. Baicalin treatment (I) attenuated LPS-induced iNOS mRNA and protein as well as nitrites generation, and (II) ameliorated LPS-elicited TLR4 and PPARγ production, and (III) inhibited p38/ATF2 phosphorylation leading to suppression of p38 signalling, and (IV) prevented PPARγ from phosphorylation contributing to maintainence of PPARγ bioactivity. However, SR-202 co-treatment (I) partially abrogated the inhibitory effect of baicalin on iNOS mRNA expression, and (II) partially reversed baicalin-inhibited p38 phosphorylation. In summary, baicalin could ameliorate LPS-induced iNOS and NO overproduction in mucosa of rat terminal ileum via inhibition of p38 signalling cascade and activation of PPARγ pathway. There existed a interplay between the two signalling pathways.

Highlights

  • The mucosa along the intestinal tract, especially the ileum, is susceptible to harmful factors such as LPS, which is a major cell wall component of Gram-negative bacteria [1]

  • Rats treated with LPS compared to the control showed higher level of inducible nitric oxide synthase (iNOS) mRNA (Fig. 2A/B)

  • Negative control small interfering RNA (siRNA) exert little effect on LPS-induced iNOS mRNA, but siRNAs against p38 and activating transcription factor 2 (ATF2) genes reduced iNOS mRNA by about 54.3% and 47.6%, respectively (Fig. 2C/D)

Read more

Summary

Introduction

The mucosa along the intestinal tract, especially the ileum, is susceptible to harmful factors such as LPS ( called endotoxin), which is a major cell wall component of Gram-negative bacteria [1]. LPS and derived pro-inflammatory molecules such asiNOS and NO may impair intestinal mucosa [2,3]. Severe devastation of intestinal mucosa plays an important role in intestinal barrier dysfunction, bacterial translocation, systemic inflammatory response syndrome and multiple organ dysfunction syndrome [4]. INOS is found to be predominantly expressed in intestinal epithelial cell, in macrophage, fibroblast, and smooth muscle cell [1,5]. P38, a member of MAPK superfamily, can trigger inflammatory response when it is activated. P38 plays a required role in the induction of iNOS expression in intestinal epithelium [2]. PPARc is expressed in intestinal epithelium and macrophage. PPARc plays an essential role in the inhibition of intestinal inflammation [10]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call